A New Approach to Fibromyalgia Treatment
In a recent interview, Dr. Shai Efrati, MD, PhD, co-founder of Aviv Scientific's Medical Advisory Board and director of the Sagol Center for Hyperbaric Medicine and Research at Shamir Medical Center, discussed recent findings on hyperbaric oxygen therapy's potential for addressing fibromyalgia caused by traumatic brain injury.
The Journey from Pilot Study to Treatment
Dr. Efrati's research began approximately ten years ago with preliminary investigations demonstrating HBOT's effectiveness in reducing fibromyalgia symptoms. The research team conceptualized fibromyalgia as a central sensitization syndrome linked to brain signal interpretation issues. Their approach involved developing a specialized HBOT protocol designed to trigger stem cell replication, stimulate new blood vessel formation, and activate repair mechanisms within brain tissue.
Evaluating the Efficacy
The research study compared two treatment approaches: traditional pharmaceutical interventions (pregabalin and duloxetine) versus a dedicated HBOT protocol. Researchers assessed multiple parameters including pain levels, quality of life metrics, and physical performance measurements before and after treatment.
Promising Results
The study revealed significant relief of fibromyalgia symptoms in patients who underwent hyperbaric oxygen therapy, offering a novel therapeutic approach targeting the underlying causes of fibromyalgia stemming from brain injuries.
Seeking More Information
This research represents a significant stride in the medical community's understanding of fibromyalgia and suggests potential treatment applications through HBOT for individuals with trauma-related fibromyalgia.
Contact us to learn more: +1 (916) 912-3214